FCH
ADMA icon

Freestone Capital Holdings’s ADMA Biologics ADMA Stock Holding History

Freestone Capital Holdings’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,953
Closed -$205K – 447
2024
Q4 		$205K Hold
11,953
– – 0.01% 422
2024
Q3 		$239K Hold
11,953
– – 0.01% 389
2024
Q2 		$134K Hold
11,953
– – ﹤0.01% 442
2024
Q1 		$78.9K Hold
11,953
– – ﹤0.01% 430
2023
Q4 		$54K Hold
11,953
– – ﹤0.01% 389
2023
Q3 		$42.8K Hold
11,953
– – ﹤0.01% 366
2023
Q2 		$44.1K Hold
11,953
– – ﹤0.01% 380
2023
Q1 		$39.6K Hold
11,953
– – ﹤0.01% 360
2022
Q4 		$46.4K Hold
11,953
– – ﹤0.01% 365
2022
Q3 		$29K Hold
11,953
– – ﹤0.01% 368
2022
Q2 		$24K Buy
+11,953
New +$23.5K ﹤0.01% 415

Other funds holding ADMA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $6.52B AUM 28.85% 1-Year Est. Return